We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $999B
1-Year Est. Return 46.22%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
+17.55%
1 Year Est. Return
+46.22%
3 Year Est. Return
+150.45%
5 Year Est. Return
+185.95%
10 Year Est. Return
+871.56%
AUM
$680B
AUM Growth
+$89.5B
Cap. Flow
-$3.61B
Cap. Flow %
-0.53%
Top 10 Hldgs %
21.1%
Holding
2,615
New
56
Increased
1,633
Reduced
713
Closed
86

Sector Composition

Rank Sector Weight
1 Technology 19.47%
2 Healthcare 18.48%
3 Consumer Discretionary 13.62%
4 Financials 13.47%
5 Communication Services 10%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UTHR icon
1401
United Therapeutics
UTHR
$20.8B
$4.84M ﹤0.01%
41,234
+393
+1% +$45.8K
ACGL icon
1402
Arch Capital
ACGL
$32.4B
$4.82M ﹤0.01%
149,243
+8,988
+6% +$274K
AGNC icon
1403
AGNC Investment
AGNC
$11.2B
$4.82M ﹤0.01%
268,009
+62,549
+30% +$1.12M
BBAR icon
1404
BBVA Argentina
BBAR
$2.56B
$4.75M ﹤0.01%
499,670
-101,400
-17% -$1.2M
LEA icon
1405
Lear
LEA
$5.93B
$4.71M ﹤0.01%
34,692
-2,683,801
-99% -$393M
YARW
1406
Yarrow Bioscience
YARW
$203M
$4.71M ﹤0.01%
167
+1
+0.6% +$24K
EHTH icon
1407
eHealth
EHTH
$23.2M
$4.67M ﹤0.01%
74,837
+65,884
+736% +$3.63M
CHK
1408
DELISTED
Chesapeake Energy Corporation
CHK
$4.64M ﹤0.01%
7,480
+5,483
+275% +$3.07M
DELL icon
1409
Dell
DELL
$346B
$4.55M ﹤0.01%
152,825
+16,047
+12% +$423K
LPX icon
1410
Louisiana-Pacific
LPX
$4.62B
$4.52M ﹤0.01%
185,402
-10,158
-5% -$248K
SJI
1411
DELISTED
South Jersey Industries, Inc.
SJI
$4.34M ﹤0.01%
135,347
-855,145
-86% -$25.9M
ITCI
1412
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$4.34M ﹤0.01%
356,063
+5,100
+1% +$65.2K
ESV
1413
DELISTED
Ensco Rowan plc
ESV
$4.3M ﹤0.01%
273,871
+20,650
+8% +$360K
SEIC icon
1414
SEI Investments
SEIC
$12.6B
$4.29M ﹤0.01%
82,057
+16,668
+25% +$834K
TC
1415
TuanChe
TC
$48.9M
$4.23M ﹤0.01%
527
– –
CSLT
1416
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
$4.23M ﹤0.01%
1,127,422
+630,698
+127% +$2M
NNN icon
1417
NNN REIT
NNN
$7.95B
$4.21M ﹤0.01%
75,976
+8,975
+13% +$465K
RGA icon
1418
Reinsurance Group of America
RGA
$16.5B
$4.18M ﹤0.01%
29,432
+1,738
+6% +$250K
MTH icon
1419
Meritage Homes
MTH
$4.24B
$4.1M ﹤0.01%
183,246
+180
+0.1% +$3.85K
HMY icon
1420
Harmony Gold Mining
HMY
$11.1B
$4.07M ﹤0.01%
+2,141,961
New +$4.2M
PE
1421
DELISTED
PARSLEY ENERGY INC
PE
$4.05M ﹤0.01%
209,834
+31,481
+18% +$578K
MATW icon
1422
Matthews International
MATW
$609M
$4.05M ﹤0.01%
109,511
-618,491
-85% -$25.2M
CC icon
1423
Chemours
CC
$2.13B
$4.01M ﹤0.01%
107,799
+6,640
+7% +$242K
YELL
1424
DELISTED
Yellow Corporation Common Stock
YELL
$3.99M ﹤0.01%
596,445
+96,288
+19% +$620K
WRI
1425
DELISTED
Weingarten Realty Investors
WRI
$3.98M ﹤0.01%
135,609
-1,031,521
-88% -$28.9M

Similar funds

T. Rowe Price Associates's Q1 2019 Portfolio in Review

As of Q1 2019, T. Rowe Price Associates held 2,615 positions worth $680B, up 15% from $591B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

T. Rowe Price Associates's Q1 2019 filing shows 56 new, 1,633 increased, 713 reduced and 86 closed positions. Its largest new stake was Fox Class B: 11,707,204 shares worth $420M. The largest sale was Tesla, an estimated $2.19B.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • T. Rowe Price Associates's largest Q1 2019 buy was Fox Class B: 11,707,204 shares worth $420M.
  • T. Rowe Price Associates added most to Meta Platforms (Facebook) in Q1 2019, an estimated $2.84B increase.
  • T. Rowe Price Associates's biggest Q1 2019 reduction was Tesla, cutting an estimated $2.19B.
  • T. Rowe Price Associates fully exited Twenty-First Century Fox, Inc. Class B in Q1 2019, selling an estimated $1.55B.
  • T. Rowe Price Associates's ten largest holdings make up 21% of its $680B portfolio in Q1 2019.
  • T. Rowe Price Associates opened 56 new positions and closed 86 in Q1 2019.
  • T. Rowe Price Associates's portfolio value rose 15% quarter-over-quarter to $680B.

Based on T. Rowe Price Associates's 13F filing for Q1 2019, filed 15 May 2019.